Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Akihito Maruyama"'
Autor:
Yoshifumi Tada, Akira Maeyama, Tomonobu Hagio, Mariko Sakai, Akihito Maruyama, Takuaki Yamamoto
Publikováno v:
Case Reports in Rheumatology, Vol 2023 (2023)
Lymphoproliferative disorders (LPDs) are serious complications associated with rheumatoid arthritis (RA) treatment that mostly occur during methotrexate (MTX) treatment. Cessation of MTX may induce regression of LPDs but is often followed by a flare
Externí odkaz:
https://doaj.org/article/3b152a295e404c9a9ca5528dabe611cd
Autor:
Syuichi Koarada, Masahiko Tsuboi, Mitsunori Komine, Yoshinobu Nakao, Yukiko Tokuda, Yukihide Ono, Satoko Tashiro, Akihito Maruyama, Nobuyuki Ono, Akihide Ohta, Yoshifumi Tada
Publikováno v:
Case Reports in Rheumatology, Vol 2015 (2015)
We report four cases of successful treatment with certolizumab pegol (CZP) of rheumatoid arthritis (RA) patients with persistent inflamed residual mono- or oligosynovitis resistant to prior TNF-α inhibitors. Although the patients were in a moderate
Externí odkaz:
https://doaj.org/article/4ec1a342c73d4b29937755ea8cdf7422
Autor:
Yuri Shirahama, Aki Hashimoto, Nobuyuki Ono, Yukiko Takeyama, Akihito Maruyama, Takuya Inoue, Yoshifumi Tada, Hiroaki Niiro
Publikováno v:
Modern Rheumatology; Mar2024, Vol. 34 Issue 2, p346-351, 6p
Autor:
Yuri Shirahama, Aki Hashimoto, Nobuyuki Ono, Yukiko Takeyama, Akihito Maruyama, Takuya Inoue, Yoshifumi Tada, Hiroaki Niiro
Publikováno v:
Modern Rheumatology.
Objectives The objective of the study is to investigate the relationships between Type 1 interferon (T1-IFN) signatures and clinical characteristics of lupus patients. Methods We examined 49 new-onset lupus patients who were diagnosed between 1999 an
Autor:
Akihide Ohta, Yohei Kirino, Hideto Nagai, Yasushi Inoue, Yutaka Chifu, Syuichi Koarada, Satomi Inokuchi, Toshiyuki Ota, Yusuke Yamauchi, Masahiro Iwamoto, Akihito Maruyama, Ayako Kokuzawa, Yoshifumi Tada
Publikováno v:
Modern Rheumatology. 31:862-868
To clarify the characteristics of patients with elderly-onset Adult-onset Still’s disease (AOSD). Patients were classified into elderly-onset (>60 years: 47 patients) and younger-onset (≤60 years: 95 patients) groups according to their age at dia
Autor:
Akihito Maruyama, Ayako Kokuzawa, Yusuke Yamauchi, Yohei Kirino, Hideto Nagai, Yasushi Inoue, Toshiyuki Ota, Yutaka Chifu, Satomi Inokuchi, Hiroki Mitoma, Mitsuteru Akahoshi, Mariko Sakai, Akihide Ohta, Masahiro Iwamoto, Yoshifumi Tada
Publikováno v:
Modern rheumatology. 32(5)
Objectives To investigate the usefulness of severity classification for predicting outcomes in patients with adult-onset Still’s disease (AOSD). Methods This was a multi-centre retrospective cohort study. AOSD patients were classified into mild, mo
Autor:
Akihito Maruyama, Ayako Kokuzawa, Yusuke Yamauchi, Yohei Kirino, Hideto Nagai, Yasushi Inoue, Toshiyuki Ota, Yutaka Chifu, Satomi Inokuchi, Hiroki Mitoma, Mitsuteru Akahoshi, Mariko Sakai, Akihide Ohta, Masahiro Iwamoto, Yoshifumi Tada
Publikováno v:
Modern Rheumatology; Sep2022, Vol. 32 Issue 5, p953-959, 7p
Autor:
Kensuke Oryoji, Hiroki Mitoma, Yuri Shirahama, Takuya Sawabe, Naoya Nishimura, Naoyasu Ueda, Hiroaki Niiro, Naoko Himuro, Yasushi Inoue, Akihito Maruyama, Yasutaka Kimoto, Takahiko Horiuchi, Katsuhisa Miyake, Atsushi Tanaka, Ayumi Uchino, Shuji Nagano, Hisako Inoue, Yoshifumi Tada, Seiji Yoshizawa, Nobuyuki Ono, Tomoya Miyamura, Yukiko Takeyama, Ayako Takamori, Shun Ichiro Ota
Publikováno v:
Modern rheumatology. 31(2)
We examined the efficacy and safety of rituximab (RTX) maintenance therapy for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in Japan.We conducted a retrospective study using a multi-center cohort database of va
Autor:
Akihito Maruyama, Takuya Inoue, Keita Kai, Yoshifumi Tada, Mariko Sakai, Yuri Sadanaga, Shuichi Koarada, Nobuyuki Ono
Publikováno v:
Rheumatology (Oxford, England). 59(4)
Objective Based on the antibody profiles of inflammatory myositis patients, we investigated the type 1 IFN (T1-IFN) signature in serum and DM skin to determine the relationship between T1-IFN and vasculopathy in anti-melanoma differentiation-associat